Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.

Nomura DK, Long JZ, Niessen S, Hoover HS, Ng SW, Cravatt BF.

Cell. 2010 Jan 8;140(1):49-61. doi: 10.1016/j.cell.2009.11.027.

2.

Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment.

Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS.

Nature. 2009 Sep 3;461(7260):109-13. doi: 10.1038/nature08268. Epub 2009 Aug 19.

3.

A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte.

Moreau A, Téruel C, Beylot M, Albalea V, Tamasi V, Umbdenstock T, Parmentier Y, Sa-Cunha A, Suc B, Fabre JM, Navarro F, Ramos J, Meyer U, Maurel P, Vilarem MJ, Pascussi JM.

Hepatology. 2009 Jun;49(6):2068-79. doi: 10.1002/hep.22907.

PMID:
19437491
4.

Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.

Donnelly C, Olsen AM, Lewis LD, Eisenberg BL, Eastman A, Kinlaw WB.

Nutr Cancer. 2009;61(1):114-22. doi: 10.1080/01635580802348666.

5.

Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways.

Goldberg IJ, Eckel RH, Abumrad NA.

J Lipid Res. 2009 Apr;50 Suppl:S86-90. doi: 10.1194/jlr.R800085-JLR200. Epub 2008 Nov 24.

6.

The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.

Hughes DT, Martel PM, Kinlaw WB, Eisenberg BL.

Cancer Invest. 2008 Mar;26(2):118-27. doi: 10.1080/07357900701522612.

7.

Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.

Pallasch CP, Schwamb J, Königs S, Schulz A, Debey S, Kofler D, Schultze JL, Hallek M, Ultsch A, Wendtner CM.

Leukemia. 2008 Mar;22(3):585-92. Epub 2007 Dec 13.

PMID:
18079738
8.

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.

Menendez JA, Lupu R.

Nat Rev Cancer. 2007 Oct;7(10):763-77. Review.

PMID:
17882277
9.

Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells.

Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K, Verhoeven G, Swinnen JV.

Cancer Res. 2007 Sep 1;67(17):8180-7.

10.

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.

Gordan JD, Thompson CB, Simon MC.

Cancer Cell. 2007 Aug;12(2):108-13. Review.

11.

Triple-negative breast cancer: therapeutic options.

Cleator S, Heller W, Coombes RC.

Lancet Oncol. 2007 Mar;8(3):235-44. Review.

PMID:
17329194
12.

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.

Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P, Hudis C, Butler J, Merkel D, Kristal A, Caan B, Michaelson R, Vinciguerra V, Del Prete S, Winkler M, Hall R, Simon M, Winters BL, Elashoff RM.

J Natl Cancer Inst. 2006 Dec 20;98(24):1767-76.

PMID:
17179478
13.

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW.

Cancer Cell. 2006 Dec;10(6):515-27.

15.

Spot 14: A marker of aggressive breast cancer and a potential therapeutic target.

Kinlaw WB, Quinn JL, Wells WA, Roser-Jones C, Moncur JT.

Endocrinology. 2006 Sep;147(9):4048-55. Epub 2006 Jun 29. Review.

PMID:
16809441
16.

Increased lipogenesis in cancer cells: new players, novel targets.

Swinnen JV, Brusselmans K, Verhoeven G.

Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):358-65. Review.

PMID:
16778563
17.

Fatty acid synthase and cancer: new application of an old pathway.

Kuhajda FP.

Cancer Res. 2006 Jun 15;66(12):5977-80. Review.

18.

Expression of "Spot 14" (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker.

Wells WA, Schwartz GN, Morganelli PM, Cole BF, Gibson JJ, Kinlaw WB.

Breast Cancer Res Treat. 2006 Jul;98(2):231-40. Epub 2006 Mar 22.

PMID:
16552628
19.
20.

The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.

van't Veer MB, Brooijmans AM, Langerak AW, Verhaaf B, Goudswaard CS, Graveland WJ, van Lom K, Valk PJ.

Haematologica. 2006 Jan;91(1):56-63.

Supplemental Content

Support Center